I want to expand on the S-1 for NGIO a bit more.
Post# of 36537
(Total Views: 287)
Posted On: 09/10/2020 2:08:40 PM
I want to expand on the S-1 for NGIO a bit more.
This is speculative from me. When the shareholders were getting the Generex / NGIO shares, Joe sent out the PR that stated the S-1 for NGIO would be going in, then a few days or so later, the other PR said I believe a Form 10 was requested from the SEC as I stated before.
I would have to believe in the months they have had since, the S-1 would have been written, modified appropriately during this time period for all that is going on, checked and rechecked and getting ready to be put in on time . With the focus for such a long time in getting NGIO listed, I can't believe they would not have been working to get the S-1 ready as NGIO is really their flagship now. NGIO is considered a separate company from Generex so Joe said the S-1 would be clean and the SEC should see it as such.
With everything else in a hold status almost, the S-1 / NGIO uplist I would think would take precedence over just about everything right about now and on par with the vaccine push.
Just my thoughts...
This is speculative from me. When the shareholders were getting the Generex / NGIO shares, Joe sent out the PR that stated the S-1 for NGIO would be going in, then a few days or so later, the other PR said I believe a Form 10 was requested from the SEC as I stated before.
I would have to believe in the months they have had since, the S-1 would have been written, modified appropriately during this time period for all that is going on, checked and rechecked and getting ready to be put in on time . With the focus for such a long time in getting NGIO listed, I can't believe they would not have been working to get the S-1 ready as NGIO is really their flagship now. NGIO is considered a separate company from Generex so Joe said the S-1 would be clean and the SEC should see it as such.
With everything else in a hold status almost, the S-1 / NGIO uplist I would think would take precedence over just about everything right about now and on par with the vaccine push.
Just my thoughts...
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼